REX FANG & Innovation Equity Premium Income ETF (NASDAQ: FEPI)

Dernières nouvelles pour REX FANG & Innovation Equity Premium Income ETF (NASDAQ:FEPI)

Technology

Consumer Cyclical

Communication Services

The Fund is an actively managed exchange-traded fund (ETF) that seeks current income while maintaining the opportunity for exposure to the share price (i.e., the price returns) of the securities of the companies comprising the Solactive FANG Innovation Index (the Index). The Fund seeks to employ its investment strategy regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods.

Tesla Inc. (usd)

Salesforce.Com Inc Common Stock Usd 0.001

AMAZON.COM INC

Palo Alto Networks Inc.

Adobe Inc

Apple Inc

Alphabet Inc-cl A

Meta Platforms, Inc.

Microsoft Corp .

Advanced Micro Devices, Inc

Palantir Techn-A

Netflix, Inc.

Intel Corporation

MICRON TECHNOLOGY INC

REX FANG & Innovation Equity Premium Income ETF

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>Piper Sandler cut <strong>Sarepta Therapeutics, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) price target from $182 to $110. Piper Sandler analyst Biren Amin maintained an Overweight rating. Sarepta Therapeutics shares closed at $53.79 on Thursday. See how other analysts view this stock.</li>
<li>Wells Fargo slashed the price target for <strong>AutoNation, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) from $194 to $176. Wells Fargo analyst Colin Langan maintained an Equal-Weight rating. AutoNation shares closed at $165.78 on Thursday. See how other analysts view this stock.</li>
<li>Barclays cut <strong>Datadog, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) price target from $180 to $125. Barclays analyst Raimo Lenschow maintained an Overweight rating. Datadog shares closed at $91.18 on Thursday. See how other analysts view this stock.</li>
<li>Ascendiant Capital slashed the price target for <strong>BioSig Technologies, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) from $2.75 to $2.5. Ascendiant Capital analyst Edward Woo maintained a Buy rating. BioSig Technologies shares closed at $0.5644 on Thursday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird cut the price target for <strong>Snap-on Incorporated</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) from $349 to $320. Baird analyst Luke Junk maintained a Neutral rating. Snap-on shares closed at $305.44 on Thursday. See how other analysts view this stock.</li>
<li>Rosenblatt increased <strong>Netflix, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) price target from $1,494 to $1,514. Rosenblatt analyst Barton Crockett maintained a Buy rating. Netflix shares settled at $973.03 on Thursday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan increased <strong>The Coca-Cola Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) price target from $74 to $78. JP Morgan analyst Andrea Teixeira maintained an Overweight rating. Coca-Cola shares closed at $73.00 on Thursday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Seaport Global cut <strong>Minerals Technologies Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTX#NYSE">MTX</a>) price target from $92 to $80. Seaport Global analyst Michael Harrison maintained a Buy rating. Minerals Technologies shares closed at $56.71 on Thursday.  <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler slashed the price target for <strong>Westamerica Bancorporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WABC#NASDAQ">WABC</a>) from $54 to $50. Piper Sandler analyst Andrew Liesch maintained a Neutral rating. Westamerica shares settled at $45.97 on Thursday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity slashed <strong>Kopin Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) price target from $2.5 to $2.25. Canaccord Genuity analyst George Gianarikas maintained a Buy rating. Kopin shares closed at $0.9054 on Thursday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
<p>Considering buying NFLX stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="594" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21100201/image-36-1024x594.png" alt="" class="wp-image-879858" style="width:555px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21100201/image-36-1024x594.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21100201/image-36-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21100201/image-36-768x446.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21100201/image-36.png 1072w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next:</strong></p>
<ul>
<li><strong> <a href="https://www.benzinga.com/25/04/44862261/top-3-materials-stocks-that-are-ticking-portfolio-bombs">Top 3 Materials Stocks That Are Ticking Portfolio Bombs</a></strong> </li>
</ul>
<p><em>Photo via Shutterstock</em></p>


News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

BSGM

DDOG

KOPN

NFLX

SRPT

WABC

Netflix To Rally More Than 55%? Here Are 10 Top Analyst Forecasts For Monday

<p>Benchmark  analyst Josh Sullivan   maintains Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) with a Buy and lowers the price target from $250 to $215.</p>


Benchmark Maintains Buy on Boeing, Lowers Price Target to $215

<p>Raymond James  analyst David Feaster   reiterates Banner (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BANR#NASDAQ">BANR</a>) with a Outperform and lowers the price target from $77 to $65.</p>


Reiteration

BANR

Raymond James Reiterates Outperform on Banner, Lowers Price Target to $65

<p>SAP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) will release its quarterly earnings report on Tuesday, 2025-04-22. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate SAP to report an <strong>earnings per share</strong> (EPS) of $1.42.</p>
<p>SAP bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS missed by $0.02, leading to a 1.11% increase in the share price on the subsequent day.</p>
<p>Here's a look at SAP's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.51</td>
<td>1.33</td>
<td>1.19</td>
<td>1.11</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.49</td>
<td>1.35</td>
<td>1.18</td>
<td>0.88</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>1.0%</td>
<td>7.000000000000001%</td>
<td>6.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244145_0.png" alt="eps graph" /></p>
<h3>SAP Share Price Analysis</h3>
<p>Shares of SAP were trading at $257.4 as of April 18. Over the last 52-week period, shares are up 33.59%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Insights on SAP</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on SAP.</p>
<p>Analysts have given SAP a total of 5 ratings, with the consensus rating being Outperform. The average one-year price target is $248.8, indicating a potential 3.34% downside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Salesforce, Palantir Technologies and Intuit, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Salesforce, with an average 1-year price target of $351.74, suggesting a potential 36.65% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Palantir Technologies, with an average 1-year price target of $97.11, suggesting a potential 62.27% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Intuit, with an average 1-year price target of $707.0, suggesting a potential 174.67% upside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Salesforce, Palantir Technologies and Intuit, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>SAP</td>
<td>Outperform</td>
<td>10.73%</td>
<td>$6.94B</td>
<td>3.70%</td>
</tr>
<tr>
<td>Salesforce</td>
<td>Neutral</td>
<td>7.60%</td>
<td>$7.78B</td>
<td>2.85%</td>
</tr>
<tr>
<td>Palantir Technologies</td>
<td>Neutral</td>
<td>36.03%</td>
<td>$652.99M</td>
<td>1.66%</td>
</tr>
<tr>
<td>Intuit</td>
<td>Outperform</td>
<td>17.04%</td>
<td>$3.03B</td>
<td>2.61%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>SAP ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.</p>
<h3>Delving into SAP's Background</h3>
<p>Founded in Germany in 1972 by former IBM employees, SAP is the world's largest provider of enterprise application software. Known as the leader in enterprise resource planning software, SAP's portfolio also includes software for supply chain management, procurement, travel and expense management, and customer relationship management, among others. The company operates in more than 180 countries and has more than 400,000 customers, approximately 80% of which are small to medium-size enterprises.</p>
<h3>Breaking Down SAP's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining SAP's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>10.73%</strong> as of 31 December, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> SAP's net margin excels beyond industry benchmarks, reaching <strong>17.07%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> SAP's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>3.7%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> SAP's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>2.23%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.23</strong>.</p>
<p><a href="https://www.benzinga.com/quote/SAP/earnings"><strong>To track all earnings releases for SAP visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

A Peek at SAP's Future Earnings

<p><a href="https://europeancapitalinsights.substack.com/p/eu-vs-china-the-new-great-game-for?r=3nmatg">Central Asia has again </a>emerged as a center of geopolitical rivalry between great powers competing for natural resources and political influence.</p>
<p>Instead of Great Britain and Russia vying for control of trade routes and territory in the 19th century's "Great Game," the European Union (EU) and China are currently courting the region's leaders. Both seek access to the region's vast oil, gas, and mineral wealth.</p>
<p>Central Asia holds massive <a target="_blank" rel="noreferrer noopener" href="https://www.euronews.com/my-europe/2025/04/04/eu-seals-new-central-asia-partnership-deal-as-debut-samarkand-summit-ends">deposits of raw materials</a>. The region has 38.6% of the world's manganese ore, 30% of chromium, 20% of lead, 12.6% of zinc, and 8.7% of titanium.</p>
<p><a href="https://x.com/eurocapinsights/status/1914255132641861790">As China expands</a> its footprint in the region, the EU seeks to increase its influence in Central Asia. Uzbekistan, Kyrgyzstan, Kazakhstan, Tajikistan, and Turkmenistan are critical for the bloc's energy supplies and green transition.</p>
<p>"Central Asia is becoming a magnet for global powers," Mehmet Fatih Oztarsu, a Senior Researcher at Hankuk University of Foreign Studies in Seoul, <a target="_blank" rel="noreferrer noopener" href="https://cepa.org/article/eu-seeks-to-match-chinese-influence-in-central-asia/">wrote</a> for the Center for European Policy Analysis (CEPA). "The EU aims to strengthen its presence and reduce Chinese influence."</p>
<p><a href="https://medium.com/@EuropeanCapitalInsights/eu-vs-china-the-new-great-game-for-central-asias-resources-ba1aa564899b">EU officials</a> are courting Central Asian leaders as they try to <a href="https://europeancapitalinsights.substack.com/p/ecb-cuts-rates-amid-trump-tariffs" target="_blank" rel="noreferrer noopener">protect the eurozone</a> from the uncertainty surrounding US trade policy under President Donald Trump. They are concerned that Trump's economic policies could further disrupt global supply chains.</p>
<h2 class="wp-block-heading">China Chips Away At EU's Role in Central Asia</h2>
<p>While the EU is the region's main investor, China is chipping away at that lead. Beijing has<a target="_blank" rel="noreferrer noopener" href="https://www.ituc-csi.org/IMG/pdf/belt_and_road_initiative_in_central_asia.pdf"> invested heavily</a> in the region as part of its Belt and Road Initiative (BRI). It has poured vast sums of funding into infrastructure projects, surveillance systems, and military assistance.</p>
<p><figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F20074331-748b-486b-a026-6e6138ef998e_1600x903.jpeg" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F20074331-748b-486b-a026-6e6138ef998e_1600x903.jpeg" alt="" /></a><figcaption class="wp-element-caption">Main investors in Central Asia, Source: <a target="_blank" rel="noreferrer noopener" href="https://www.consilium.europa.eu/en/infographics/eu-central-asia-trade/">Council of the European Union</a></figcaption></figure></p>
<p>China accounts for roughly 22% of <a target="_blank" rel="noreferrer noopener" href="https://foreignaffairs.house.gov/china-snapshot-project-central-asia-2/">Central Asian exports </a>and 37% of their imports. This trade grew to $89 billion in 2023, representing a 27% increase from the previous year. Significantly, China has surpassed Russia as the region's largest trading partner, according to <a target="_blank" rel="noreferrer noopener" href="https://cepa.org/article/china-uses-crises-to-build-central-asia-influence/">CEPA</a>.</p>
<p>Along with closer ties, though, Kyrgyzstan and Tajikistan now owe nearly half of their sovereign debt to China. Public concern about falling into a Chinese debt trap has sparked more than <a target="_blank" rel="noreferrer noopener" href="https://www.orfonline.org/research/amid-russia-ukraine-conflict-advantage-china-in-central-asia">150 protests</a> across the region since 2015.</p>
<p>China's financing aims to expand its geopolitical influence, secure trade routes, and build large-scale infrastructure. In comparison, the EU instead offers loans designed" to accelerate economic transformation, adaptation to a free-market economy, and promotion of human rights," Oztarsu wrote.</p>
<p><figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F4fdee050-db9e-4ba2-ab19-bdf75169d34b_1105x707.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F4fdee050-db9e-4ba2-ab19-bdf75169d34b_1105x707.png" alt="" /></a><figcaption class="wp-element-caption">Source: <a target="_blank" rel="noreferrer noopener" href="https://foreignaffairs.house.gov/china-snapshot-project-central-asia-2/">US House Foreign Affairs Committee</a></figcaption></figure></p>
<h2 class="wp-block-heading">Beijing Makes Political Overtures in Central Asia</h2>
<p>Beijing has made political overtures in the region. President Xi Jinping visited Kazakhstan for the fifth time in July last year since assuming power in 2012.</p>
<p>Apart from Russia, this fact marks Kazakhstan as one of the Chinese leader's most frequently visited nations, alongside the US and France. President Xi has visited Russia more frequently, nine times, according to the <a target="_blank" rel="noreferrer noopener" href="https://carnegieendowment.org/posts/2024/07/what-does-xi-jinping-want-from-central-asia?lang=en">Carnegie Endowment for International Peace</a>.</p>
<p><figure class="wp-block-image is-resized"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F61b30952-e9d5-4a06-950a-2cf62b61bfc2_807x720.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F61b30952-e9d5-4a06-950a-2cf62b61bfc2_807x720.png" alt="" style="width:920px;height:auto" /></a></figure></p>
<p>"China's growing attention to Central Asia is perceived as a harbinger of tectonic shifts in regional geopolitics," <a target="_blank" rel="noreferrer noopener" href="https://carnegieendowment.org/people/temur-umarov?lang=en">Temur Umarov</a>, a fellow at the Carnegie Russia Eurasia Center, wrote last year.</p>
<p>China's Central Asian push has not gone unnoticed in Brussels.</p>
<h2 class="wp-block-heading">EU Maneuvers To Offset China's Expansion</h2>
<p>EU representatives and the five former Soviet republics of Central Asia met on <a target="_blank" rel="noreferrer noopener" href="https://www.consilium.europa.eu/en/press/press-releases/2025/04/04/joint-press-release-following-the-first-eu-central-asia-summit/">April 4</a> to strengthen their strategic partnership. The first <a target="_blank" rel="noreferrer noopener" href="https://data.consilium.europa.eu/doc/document/ST-7745-2025-REV-1/en/pdf">EU-Central Asia Summit</a> in Samarkand, Uzbekistan, focused on expanding trade and EU investment.</p>
<p>"After years of successful cooperation it is time to take our partnership with Central Asia to the next level, deepening trade, strengthening regional collaboration and expanding people-to-people ties," António Costa, President of the European Council, said. "The EU remains a reliable forward-looking partner for Central Asia, investing in its long-term sustainable development for mutual, long-lasting benefit."</p>
<p>The delegations discussed the contemporary developments of the Trans-Caspian International Transport Route (TITR). It connects the two regions via Central Asia, the Caspian Sea, the South Caucasus, and Turkey.</p>
<p>Its freight transportation volume increased by <a target="_blank" rel="noreferrer noopener" href="https://caspiannews.com/news-detail/trans-caspian-international-transport-route-sets-new-record-in-2024-2024-12-18-27/">63% to 4.1 million tons</a> in the first 11 months of 2024. The <a target="_blank" rel="noreferrer noopener" href="https://caspiannews.com/news-detail/trans-caspian-international-transport-route-sets-new-record-in-2024-2024-12-18-27/">TITR Coordination Center</a> aims to enhance its competitiveness by reducing the transit time between Europe and China to under 15 days.</p>
<p>Bypassing Russia, the TITR has also become an alternative to China's BRI. The corridor became more critical for China and Europe after Russia invaded Ukraine. The sanctions imposed on Moscow exposed the EU to global supply chain disruptions that drove eurozone inflation to 10.6% in October 2022.</p>
<h2 class="wp-block-heading">EU Boosts Investments In Central Asia</h2>
<p>The European Commission President, Ursula von der Leyen, pledged EU investments of €<a target="_blank" rel="noreferrer noopener" href="https://www.euronews.com/my-europe/2025/04/04/eu-seals-new-central-asia-partnership-deal-as-debut-samarkand-summit-ends">12 billion</a>. The bloc allocated €3 billion for transportation and €2.5 billion for raw materials projects, <a target="_blank" rel="noreferrer noopener" href="https://x.com/vonderleyen/status/1907803357252624762">von der Leyen</a> said.</p>
<p>The EU will also provide €6.4 billion for water, energy, and climate protection. It pledged an additional €<a target="_blank" rel="noreferrer noopener" href="https://www.consilium.europa.eu/en/press/press-releases/2025/04/04/joint-press-release-following-the-first-eu-central-asia-summit/">10 million</a>&nbsp;to enhance Central Asia's connectivity.</p>
<p>"Countries in the region –particularly Kazakhstan and Uzbekistan – have become more significant partners for the EU and its member states," Marcin Popławski, a research fellow for the Centre for Eastern Studies,<a target="_blank" rel="noreferrer noopener" href="https://www.osw.waw.pl/en/publikacje/analyses/2025-04-09/eu-central-asia-summit-samarkand-economy-comes-first"> wrote </a>on April 9. That is "due to increased exports of oil and uranium, a shift facilitated by their cautious stance on the war in Ukraine," Popławski added.</p>
<p>In the first quarter of 2024, Kazakhstan supplied 10.9% of the EU's petroleum oil imports, as reported by <a target="_blank" rel="noreferrer noopener" href="https://ec.europa.eu/eurostat/web/products-eurostat-news/w/ddn-20240701-1">Eurostat</a>. Kazakhstan, the largest economy in the region, supplies 19 of the EU's 34 critical raw materials, according to Eurostat.</p>
<h2 class="wp-block-heading">European Companies Have Presence in Central Asia</h2>
<p>European companies have significant interests in the region. France's TotalEnergies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) holds <a target="_blank" rel="noreferrer noopener" href="https://totalenergies.com/kazakhstan">a 16.8% stake</a> in the North Caspian Project consortium to develop the Kashagan oil field.</p>
<p>Dutch Shell plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) <a target="_blank" rel="noreferrer noopener" href="https://reports.shell.com/investors-handbook/2011/upstream/asia/kazakhstan.html">has a 16.8% stake </a>in the Kashagan oil field, one of the world's largest offshore fields. Shell also holds a 5.4% interest in the Caspian Pipeline Consortium, which exports production from western Kazakhstan to the Black Sea.</p>
<p>To support European corporate interests, the EU has started to focus more heavily on trade. This approach aligns with the expectations of the Central Asian states, according to Popławski.</p>
<p>"The relationship now focuses on targeted cooperation, particularly in areas such as raw materials and transport," Poplawski said. This has expanded "since Russia's full-scale invasion of Ukraine," he added.</p>
<p><strong><em>Disclaimer</em></strong>:</p>
<p>Any opinions expressed in this article are not to be considered investment advice and are solely those of the authors. European Capital Insights is not responsible for any financial decisions made based on the contents of this article. Readers may use this article for information and educational purposes only.&nbsp;</p>
<p>This article is from an unpaid external contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content or accuracy.</p>


Asia

Macro Economic Events

Eurozone

Politics

Econ #s

Opinion

ETFs

General

SHEL

EU vs China: The Power Struggle For Central Asia's Resources

<p>Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Baker Hughes to report an <strong>earnings per share</strong> (EPS) of $0.48.</p>
<p>Anticipation surrounds Baker Hughes's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings History Snapshot</h3>
<p>The company's EPS beat by $0.07 in the last quarter, leading to a 3.54% increase in the share price on the following day.</p>
<p>Here's a look at Baker Hughes's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.63</td>
<td>0.61</td>
<td>0.49</td>
<td>0.40</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.70</td>
<td>0.67</td>
<td>0.57</td>
<td>0.43</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>4.0%</td>
<td>3.0%</td>
<td>6.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244137_0.png" alt="eps graph" /></p>
<h3>Baker Hughes Share Price Analysis</h3>
<p>Shares of Baker Hughes were trading at $38.91 as of April 18. Over the last 52-week period, shares are up 16.27%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Insights on Baker Hughes</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Baker Hughes.</p>
<p>A total of 13 analyst ratings have been received for Baker Hughes, with the consensus rating being Outperform. The average one-year price target stands at $53.38, suggesting a potential 37.19% upside.</p>
<h3>Comparing Ratings Among Industry Peers</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Schlumberger, Halliburton and TechnipFMC, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Schlumberger, with an average 1-year price target of $52.88, suggesting a potential 35.9% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Halliburton, with an average 1-year price target of $32.83, suggesting a potential 15.63% downside.</li>
<li>Analysts currently favor an Outperform trajectory for TechnipFMC, with an average 1-year price target of $39.33, suggesting a potential 1.08% upside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
<p>Within the peer analysis summary, vital metrics for Schlumberger, Halliburton and TechnipFMC are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Baker Hughes</td>
<td>Outperform</td>
<td>7.74%</td>
<td>$1.53B</td>
<td>7.13%</td>
</tr>
<tr>
<td>Schlumberger</td>
<td>Outperform</td>
<td>3.27%</td>
<td>$1.96B</td>
<td>5.14%</td>
</tr>
<tr>
<td>Halliburton</td>
<td>Neutral</td>
<td>-2.25%</td>
<td>$1.03B</td>
<td>5.91%</td>
</tr>
<tr>
<td>TechnipFMC</td>
<td>Outperform</td>
<td>13.94%</td>
<td>$387M</td>
<td>7.07%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Baker Hughes ranks highest in revenue growth among its peers. It also leads in gross profit margin. However, it has the lowest return on equity. Overall, Baker Hughes is positioned favorably compared to its peers in terms of revenue growth and gross profit, but lags behind in return on equity.</p>
<h3>All You Need to Know About Baker Hughes</h3>
<p>Following a 2022 reorganization, Baker Hughes operates across two segments: oilfield services and equipment, and industrial and energy technology. The firm's oilfield services and equipment segment, or OFSE, is one of the Big Three oilfield service players, along with SLB and Halliburton, and mostly supplies to hydrocarbon developers and producers, including national oil companies, major integrated firms, and independents. Markets outside of North America buy roughly three quarters of the firm's OFSE. Baker Hughes' industrial and energy technology segment manufactures and sells turbines, compressors, pumps, valves, and related testing and monitoring services across various energy and industrial applications.</p>
<h3>Breaking Down Baker Hughes's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Baker Hughes's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>7.74%</strong> as of 31 December, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Energy sector.</p>
<p><strong>Net Margin:</strong> Baker Hughes's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>16.01%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Baker Hughes's ROE excels beyond industry benchmarks, reaching <strong>7.13%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Baker Hughes's ROA excels beyond industry benchmarks, reaching <strong>3.11%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Baker Hughes's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.36</strong>.</p>
<p><a href="https://www.benzinga.com/quote/BKR/earnings"><strong>To track all earnings releases for Baker Hughes visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What to Expect from Baker Hughes's Earnings

<p>Northrop Grumman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-22. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Northrop Grumman will report an <strong>earnings per share</strong> (EPS) of $6.34.</p>
<p>Anticipation surrounds Northrop Grumman's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.04, leading to a 0.81% increase in the share price the following trading session.</p>
<p>Here's a look at Northrop Grumman's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>6.35</td>
<td>6.07</td>
<td>5.93</td>
<td>5.79</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>6.39</td>
<td>7</td>
<td>6.36</td>
<td>6.32</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244122_0.png" alt="eps graph" /></p>
<h3>Tracking Northrop Grumman's Stock Performance</h3>
<p>Shares of Northrop Grumman were trading at $540.39 as of April 18. Over the last 52-week period, shares are up 12.5%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Views on Northrop Grumman</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Northrop Grumman.</p>
<p>A total of 10 analyst ratings have been received for Northrop Grumman, with the consensus rating being Outperform. The average one-year price target stands at $572.3, suggesting a potential 5.9% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of General Dynamics, Howmet Aerospace and Lockheed Martin, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for General Dynamics, with an average 1-year price target of $293.15, suggesting a potential 45.75% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Howmet Aerospace, with an average 1-year price target of $136.25, suggesting a potential 74.79% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Lockheed Martin, with an average 1-year price target of $508.83, suggesting a potential 5.84% downside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for General Dynamics, Howmet Aerospace and Lockheed Martin, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Northrop Grumman</td>
<td>Outperform</td>
<td>0.45%</td>
<td>$1.93B</td>
<td>8.42%</td>
</tr>
<tr>
<td>General Dynamics</td>
<td>Neutral</td>
<td>14.31%</td>
<td>$2.08B</td>
<td>5.10%</td>
</tr>
<tr>
<td>Howmet Aerospace</td>
<td>Outperform</td>
<td>9.24%</td>
<td>$602M</td>
<td>7.02%</td>
</tr>
<tr>
<td>Lockheed Martin</td>
<td>Neutral</td>
<td>-1.34%</td>
<td>$690M</td>
<td>7.79%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Northrop Grumman ranks highest in Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.</p>
<h3>All You Need to Know About Northrop Grumman</h3>
<p>Northrop Grumman Corp is a diversified company which is aligned in four operating sectors, which also comprise our reportable segments namely Aeronautics Systems, Defense Systems, Mission Systems and Space Systems. The aerospace segment designs and builds military aircraft, including the F-35, Global Hawk drones, and the B-21 bomber. Defense systems develops artillery, missile systems, and missile defense technologies. Mission systems focuses on radar, navigation, and communication systems, while space systems manufactures satellites, sensors, and rocket motors.</p>
<h3>Key Indicators: Northrop Grumman's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Revenue Growth:</strong> Northrop Grumman's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>0.45%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Northrop Grumman's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>11.83%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>8.42%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Northrop Grumman's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>2.59%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>1.08</strong>, caution is advised due to increased financial risk.</p>
<p><a href="https://www.benzinga.com/quote/NOC/earnings"><strong>To track all earnings releases for Northrop Grumman visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Northrop Grumman's Earnings Outlook

<p>Northern Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRS#NASDAQ">NTRS</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-22. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Northern Trust will report an <strong>earnings per share</strong> (EPS) of $1.84.</p>
<p>The market awaits Northern Trust's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings History Snapshot</h3>
<p>The company's EPS beat by $0.26 in the last quarter, leading to a 1.26% increase in the share price on the following day.</p>
<p>Here's a look at Northern Trust's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2</td>
<td>1.74</td>
<td>1.90</td>
<td>1.44</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.26</td>
<td>1.96</td>
<td>1.78</td>
<td>1.70</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>0.0%</td>
<td>0.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244113_0.png" alt="eps graph" /></p>
<h3>Market Performance of Northern Trust's Stock</h3>
<p>Shares of Northern Trust were trading at $88.295 as of April 18. Over the last 52-week period, shares are up 4.55%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Observations about Northern Trust</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Northern Trust.</p>
<p>With 13 analyst ratings, Northern Trust has a consensus rating of Neutral. The average one-year price target is $113.69, indicating a potential 28.76% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Blue Owl Capital, Franklin Resources and SEI Inv, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Blue Owl Capital, with an average 1-year price target of $25.6, suggesting a potential 71.01% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Franklin Resources, with an average 1-year price target of $19.62, suggesting a potential 77.78% downside.</li>
<li>Analysts currently favor an Neutral trajectory for SEI Inv, with an average 1-year price target of $84.2, suggesting a potential 4.64% downside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for Blue Owl Capital, Franklin Resources and SEI Inv, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>T. Rowe Price Group</td>
<td>Neutral</td>
<td>11.11%</td>
<td>$947.60M</td>
<td>4.16%</td>
</tr>
<tr>
<td>Blue Owl Capital</td>
<td>Outperform</td>
<td>27.80%</td>
<td>$336.88M</td>
<td>1.00%</td>
</tr>
<tr>
<td>Franklin Resources</td>
<td>Neutral</td>
<td>13.08%</td>
<td>$1.83B</td>
<td>1.19%</td>
</tr>
<tr>
<td>SEI Inv</td>
<td>Neutral</td>
<td>14.92%</td>
<td>$297.69M</td>
<td>6.76%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Northern Trust is positioned in the middle among its peers for Consensus rating. It ranks at the top for Revenue Growth, indicating strong performance in this area. In terms of Gross Profit, Northern Trust is at the bottom compared to its peers. For Return on Equity, Northern Trust is positioned in the middle range.</p>
<h3>Unveiling the Story Behind Northern Trust</h3>
<p>Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2024, Northern Trust had assets under custody or administration of $16.8 trillion and assets under management of $1.6 trillion.</p>
<h3>Understanding the Numbers: Northern Trust's Finances</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Northern Trust's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>26.81%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> Northern Trust's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>22.81%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Northern Trust's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>3.76%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Northern Trust's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>0.29%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>1.12</strong>, Northern Trust adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/NTRS/earnings"><strong>To track all earnings releases for Northern Trust visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


NTRS

Preview: Northern Trust's Earnings

<p>3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect 3M to report an <strong>earnings per share</strong> (EPS) of $1.75.</p>
<p>Investors in 3M are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.02, leading to a 1.52% increase in the share price the following trading session.</p>
<p>Here's a look at 3M's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.66</td>
<td>1.90</td>
<td>1.68</td>
<td>1.96</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.68</td>
<td>1.98</td>
<td>1.93</td>
<td>2.39</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>2.0%</td>
<td>-3.0%</td>
<td>23.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244104_0.png" alt="eps graph" /></p>
<h3>Tracking 3M's Stock Performance</h3>
<p>Shares of 3M were trading at $130.21 as of April 18. Over the last 52-week period, shares are up 38.62%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Observations about 3M</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on 3M.</p>
<p>A total of 11 analyst ratings have been received for 3M, with the consensus rating being Outperform. The average one-year price target stands at $149.09, suggesting a potential 14.5% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of  and Honeywell Intl, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Honeywell Intl, with an average 1-year price target of $229.75, suggesting a potential 76.45% upside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
<p>The peer analysis summary outlines pivotal metrics for  and Honeywell Intl, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>3M</td>
<td>Outperform</td>
<td>0.13%</td>
<td>$2.27B</td>
<td>17.16%</td>
</tr>
<tr>
<td>Honeywell Intl</td>
<td>Neutral</td>
<td>6.86%</td>
<td>$3.67B</td>
<td>7.13%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>3M outperforms its peers in revenue growth and gross profit, ranking at the top. However, it lags behind in return on equity, placing in the middle compared to its peers.</p>
<h3>All You Need to Know About 3M</h3>
<p>3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.</p>
<h3>A Deep Dive into 3M's Financials</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Revenue Growth:</strong> 3M's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>0.13%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> 3M's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>12.11%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> 3M's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>17.16%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> 3M's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.8%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>3.56</strong>, 3M adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/MMM/earnings"><strong>To track all earnings releases for 3M visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What's Next: 3M's Earnings Preview

<p><strong>Verizon Communications</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Verizon Communications will report an <strong>earnings per share</strong> (EPS) of $1.15. </p>
<p>Anticipation surrounds Verizon Communications's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>In the previous earnings release, the company missed EPS by $0.00, leading to a 0.0% drop in the share price the following trading session.</p>
<p>Here's a look at Verizon Communications's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.1</td>
<td>1.18</td>
<td>1.15</td>
<td>1.12</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.1</td>
<td>1.19</td>
<td>1.15</td>
<td>1.15</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>3.0%</td>
<td>-1.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244093_0.png" alt="eps graph" /></p>
<h3>Market Performance of Verizon Communications's Stock</h3>
<p>Shares of Verizon Communications were trading at $44.04 as of April 18. Over the last 52-week period, shares are up 11.13%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/VZ/earnings"><strong>To track all earnings releases for Verizon Communications visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Exploring Verizon Communications's Earnings Expectations

<p>MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect MSCI to report an <strong>earnings per share</strong> (EPS) of $3.93.</p>
<p>The announcement from MSCI is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Historical Earnings Performance</h3>
<p>The company's EPS beat by $0.23 in the last quarter, leading to a 0.39% drop in the share price on the following day.</p>
<p>Here's a look at MSCI's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>3.95</td>
<td>3.77</td>
<td>3.55</td>
<td>3.45</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>4.18</td>
<td>3.86</td>
<td>3.64</td>
<td>3.52</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>-2.0%</td>
<td>-2.0%</td>
<td>4.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244082_0.png" alt="eps graph" /></p>
<h3>Tracking MSCI's Stock Performance</h3>
<p>Shares of MSCI were trading at $546.89 as of April 18. Over the last 52-week period, shares are up 21.53%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MSCI/earnings"><strong>To track all earnings releases for MSCI visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MSCI

Earnings Outlook For MSCI

<p>In the last three months, 9 analysts have published ratings on Snap-on (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Snap-on, presenting an average target of $357.67, a high estimate of $400.00, and a low estimate of $320.00. This upward trend is apparent, with the current average reflecting a 0.33% increase from the previous average price target of $356.50.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244078_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>A comprehensive examination of how financial experts perceive Snap-on is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;    Analyst Firm    &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;Luke Junk           &#x7C;Baird               &#x7C;Lowers         &#x7C;Neutral        &#x7C;             $320.00&#x7C;$349.00             &#x7C;<br />
&#x7C;Gary Prestopino     &#x7C;Barrington Research &#x7C;Maintains      &#x7C;Outperform     &#x7C;             $350.00&#x7C;$350.00             &#x7C;<br />
&#x7C;Luke Junk           &#x7C;Baird               &#x7C;Lowers         &#x7C;Neutral        &#x7C;             $349.00&#x7C;$358.00             &#x7C;<br />
&#x7C;Gary Prestopino     &#x7C;Barrington Research &#x7C;Maintains      &#x7C;Outperform     &#x7C;             $350.00&#x7C;$350.00             &#x7C;<br />
&#x7C;David Macgregor     &#x7C;Longbow Research    &#x7C;Announces      &#x7C;Buy            &#x7C;             $400.00&#x7C;-                   &#x7C;<br />
&#x7C;Ivan Feinseth       &#x7C;Tigress Financial   &#x7C;Raises         &#x7C;Buy            &#x7C;             $390.00&#x7C;$385.00             &#x7C;<br />
&#x7C;Gary Prestopino     &#x7C;Barrington Research &#x7C;Maintains      &#x7C;Outperform     &#x7C;             $350.00&#x7C;$350.00             &#x7C;<br />
&#x7C;Gary Prestopino     &#x7C;Barrington Research &#x7C;Maintains      &#x7C;Outperform     &#x7C;             $350.00&#x7C;$350.00             &#x7C;<br />
&#x7C;Gary Prestopino     &#x7C;Barrington Research &#x7C;Maintains      &#x7C;Outperform     &#x7C;             $360.00&#x7C;$360.00             &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Snap-on. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Snap-on compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Snap-on's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Snap-on's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SNA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Snap-on analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Snap-on</h2>
<p>Snap-on manufactures premium tools and software for repair professionals. Hand tools are sold through a franchisee-operated mobile van network that serve auto technicians who purchase tools at their own expense. A unique element of its business model is that franchisees bear significant risk, as they must invest in the mobile van, inventory, and software. At the same time, franchisees extend personal credit directly to technicians on an individual tool basis. Snap-on currently operates three segments: repair systems and information, commercial and industrial, and tools. Its finance arm provides financing to franchisees to run their operations, which includes offering loans and leases for mobile vans.</p>
<h3>Snap-on's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3M period, Snap-on faced challenges, resulting in a decline of approximately <strong>-3.48%</strong> in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Snap-on's net margin is impressive, surpassing industry averages. With a net margin of <strong>21.08%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Snap-on's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>4.41%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Snap-on's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>3.01%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.23</strong>, Snap-on adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


What 9 Analyst Ratings Have To Say About Snap-on

<p>Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-22. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Lockheed Martin will report an <strong>earnings per share</strong> (EPS) of $6.41.</p>
<p>Anticipation surrounds Lockheed Martin's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings History Snapshot</h3>
<p>The company's EPS beat by $1.06 in the last quarter, leading to a 0.68% drop in the share price on the following day.</p>
<p>Here's a look at Lockheed Martin's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>6.61</td>
<td>6.50</td>
<td>6.46</td>
<td>5.81</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>7.67</td>
<td>6.84</td>
<td>7.11</td>
<td>6.33</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>3.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244071_0.png" alt="eps graph" /></p>
<h3>Lockheed Martin Share Price Analysis</h3>
<p>Shares of Lockheed Martin were trading at $464.08 as of April 18. Over the last 52-week period, shares are up 0.02%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Insights on Lockheed Martin</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Lockheed Martin.</p>
<p>The consensus rating for Lockheed Martin is Neutral, derived from 12 analyst ratings. An average one-year price target of $508.83 implies a potential 9.64% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Northrop Grumman, General Dynamics and Howmet Aerospace, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Northrop Grumman, with an average 1-year price target of $572.3, suggesting a potential 23.32% upside.</li>
<li>Analysts currently favor an Neutral trajectory for General Dynamics, with an average 1-year price target of $293.15, suggesting a potential 36.83% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Howmet Aerospace, with an average 1-year price target of $136.25, suggesting a potential 70.64% downside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
<p>The peer analysis summary presents essential metrics for Northrop Grumman, General Dynamics and Howmet Aerospace, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lockheed Martin</td>
<td>Neutral</td>
<td>-1.34%</td>
<td>$690M</td>
<td>7.79%</td>
</tr>
<tr>
<td>Northrop Grumman</td>
<td>Outperform</td>
<td>0.45%</td>
<td>$1.93B</td>
<td>8.42%</td>
</tr>
<tr>
<td>General Dynamics</td>
<td>Neutral</td>
<td>14.31%</td>
<td>$2.08B</td>
<td>5.10%</td>
</tr>
<tr>
<td>Howmet Aerospace</td>
<td>Outperform</td>
<td>9.24%</td>
<td>$602M</td>
<td>7.02%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Lockheed Martin ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, Lockheed Martin is at the bottom compared to its peers.</p>
<h3>Discovering Lockheed Martin: A Closer Look</h3>
<p>Lockheed Martin is the world's largest defense contractor and has dominated the Western market for high-end fighter aircraft since it won the F-35 Joint Strike Fighter program in 2001. Aeronautics is Lockheed's largest segment, which derives upward of two-thirds of its revenue from the F-35. Lockheed's remaining segments are rotary and mission systems, mainly encompassing the Sikorsky helicopter business; missiles and fire control, which creates missiles and missile defense systems; and space systems, which produces satellites and receives equity income from the United Launch Alliance joint venture.</p>
<h3>Lockheed Martin's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Lockheed Martin's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately <strong>-1.34%</strong>. This indicates a decrease in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Lockheed Martin's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>2.83%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Lockheed Martin's ROE excels beyond industry benchmarks, reaching <strong>7.79%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Lockheed Martin's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.95%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Lockheed Martin's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>3.2</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<p><a href="https://www.benzinga.com/quote/LMT/earnings"><strong>To track all earnings releases for Lockheed Martin visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Lockheed Martin's Earnings: A Preview

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Broadcom</strong>.</p>
<p>Looking at options history for Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) we detected 17 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 47% of the investors opened trades with bullish expectations and 35% with bearish.</p>
<p>From the overall spotted trades, 6 are puts, for a total amount of $403,698 and 11, calls, for a total amount of $514,031.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $240.0 for Broadcom, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Broadcom's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Broadcom's substantial trades, within a strike price spectrum from $100.0 to $240.0 over the preceding 30 days.</p>
<h3>Broadcom Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244067_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AVGO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$9.05</td>
<td>$8.8</td>
<td>$9.0</td>
<td>$115.00</td>
<td>$157.5K</td>
<td>319</td>
<td align="right">175</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$72.55</td>
<td>$71.55</td>
<td>$72.0</td>
<td>$100.00</td>
<td>$86.4K</td>
<td>903</td>
<td align="right">12</td>
</tr>
<tr>
<td>AVGO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$56.9</td>
<td>$56.3</td>
<td>$56.3</td>
<td>$210.00</td>
<td>$73.1K</td>
<td>500</td>
<td align="right">13</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/20/26</td>
<td>$21.7</td>
<td>$21.25</td>
<td>$21.52</td>
<td>$190.00</td>
<td>$73.1K</td>
<td>228</td>
<td align="right">34</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$6.4</td>
<td>$6.2</td>
<td>$6.3</td>
<td>$175.00</td>
<td>$63.0K</td>
<td>7.8K</td>
<td align="right">107</td>
</tr>
</tbody>
</table>
</p>
<h3>About Broadcom</h3>
<p>Broadcom is the sixth-largest semiconductor company globally and has expanded into various software businesses, with over $30 billion in annual revenue. It sells 17 core semiconductor product lines across wireless, networking, broadband, storage, and industrial markets. It is primarily a fabless designer but holds some manufacturing in-house, like for its best-of-breed FBAR filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments.Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as Brocade, CA Technologies, and Symantec in software.</p>
<p>In light of the recent options history for Broadcom, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of Broadcom</h3>
<ul>
<li>With a volume of 1,103,007, the price of AVGO is down -2.71% at $166.36. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 51 days.</li>
</ul>
<h3>What Analysts Are Saying About Broadcom</h3>
<p>2 market experts have recently issued ratings for this stock, with a consensus target price of $225.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Citigroup persists with their Buy rating on Broadcom, maintaining a target price of $210.<br />
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Broadcom, targeting a price of $240. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Broadcom with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Options

AVGO

A Closer Look at Broadcom's Options Market Dynamics

<p>Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Lucid Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) in the last three months.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Lucid Group, revealing an average target of $3.0, a high estimate of $5.00, and a low estimate of $1.00. Experiencing a 6.54% decline, the current average is now lower than the previous average price target of $3.21. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244066_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The standing of Lucid Group among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;    Analyst Firm    &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;Ben Kallo           &#x7C;Baird               &#x7C;Raises         &#x7C;Neutral        &#x7C;               $3.00&#x7C;$2.00               &#x7C;<br />
&#x7C;Andres Sheppard     &#x7C;Cantor Fitzgerald   &#x7C;Maintains      &#x7C;Neutral        &#x7C;               $3.00&#x7C;$3.00               &#x7C;<br />
&#x7C;Andres Sheppard     &#x7C;Cantor Fitzgerald   &#x7C;Maintains      &#x7C;Neutral        &#x7C;               $3.00&#x7C;$3.00               &#x7C;<br />
&#x7C;Adam Jonas          &#x7C;Morgan Stanley      &#x7C;Announces      &#x7C;Equal-Weight   &#x7C;               $3.00&#x7C;-                   &#x7C;<br />
&#x7C;Mark Zgutowicz      &#x7C;Benchmark           &#x7C;Maintains      &#x7C;Buy            &#x7C;               $5.00&#x7C;$5.00               &#x7C;<br />
&#x7C;Stephen Gengaro     &#x7C;Stifel              &#x7C;Lowers         &#x7C;Hold           &#x7C;               $3.00&#x7C;$3.50               &#x7C;<br />
&#x7C;Andres Sheppard     &#x7C;Cantor Fitzgerald   &#x7C;Maintains      &#x7C;Neutral        &#x7C;               $3.00&#x7C;$3.00               &#x7C;<br />
&#x7C;John Murphy         &#x7C;B of A Securities   &#x7C;Lowers         &#x7C;Underperform   &#x7C;               $1.00&#x7C;$3.00               &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Lucid Group. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Lucid Group compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>To gain a panoramic view of Lucid Group's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/LCID/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Lucid Group analyst ratings.</strong></a></p>
<h2>Discovering Lucid Group: A Closer Look</h2>
<p>Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations and through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.</p>
<h3>Key Indicators: Lucid Group's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Lucid Group's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>49.2%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>-271.63%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Lucid Group's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>-19.43%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Lucid Group's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-7.02%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.64</strong>, Lucid Group adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


LCID

The Analyst Verdict: Lucid Group In The Eyes Of 8 Experts

<p>Financial giants have made a conspicuous bearish move on Boeing. Our analysis of options history for Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) revealed 19 unusual trades.</p>
<p>Delving into the details, we found 31% of traders were bullish, while 52% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $649,230, and 11 were calls, valued at $864,820.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $130.0 to $210.0 for Boeing over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for Boeing options trades today is 2138.62 with a total volume of 5,193.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Boeing's big money trades within a strike price range of $130.0 to $210.0 over the last 30 days.</p>
<h3>Boeing Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244062_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$14.0</td>
<td>$13.65</td>
<td>$13.65</td>
<td>$150.00</td>
<td>$273.0K</td>
<td>4.4K</td>
<td>301</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$17.4</td>
<td>$17.0</td>
<td>$17.25</td>
<td>$160.00</td>
<td>$224.2K</td>
<td>2.8K</td>
<td>145</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/25/25</td>
<td>$1.39</td>
<td>$1.03</td>
<td>$1.34</td>
<td>$145.00</td>
<td>$165.7K</td>
<td>2.6K</td>
<td>1.2K</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$8.85</td>
<td>$8.25</td>
<td>$8.65</td>
<td>$195.00</td>
<td>$142.7K</td>
<td>1.5K</td>
<td>165</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.6</td>
<td>$170.00</td>
<td>$90.0K</td>
<td>6.3K</td>
<td>232</td>
</tr>
</tbody>
</table>
</p>
<h3>About Boeing</h3>
<p>Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and Global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed and Northrop to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.</p>
<p>Following our analysis of the options activities associated with Boeing, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Boeing Standing Right Now?</h3>
<ul>
<li>With a trading volume of 718,542, the price of BA is down by -2.3%, reaching $158.18.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 2 days from now.</li>
</ul>
<h3>What The Experts Say On Boeing</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $111.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Underweight rating on Boeing with a target price of $111. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Boeing options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


What the Options Market Tells Us About Boeing

<p><strong>Elevance Health</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Elevance Health will report an <strong>earnings per share</strong> (EPS) of $10.28. </p>
<p>Investors in Elevance Health are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS missed by $0.02, leading to a 0.1% drop in the share price on the subsequent day.</p>
<p>Here's a look at Elevance Health's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>3.86</td>
<td>9.66</td>
<td>10.01</td>
<td>10.53</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>3.84</td>
<td>8.37</td>
<td>10.12</td>
<td>10.64</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>-3.0%</td>
<td>-3.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244059_0.png" alt="eps graph" /></p>
<h3>Market Performance of Elevance Health's Stock</h3>
<p>Shares of Elevance Health were trading at $424.53 as of April 18. Over the last 52-week period, shares are down 21.65%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<h3>Analyst Views on Elevance Health</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Elevance Health.</p>
<p>A total of 8 analyst ratings have been received for Elevance Health, with the consensus rating being Outperform. The average one-year price target stands at $492.8, suggesting a potential 16.08% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Molina Healthcare, HealthEquity and Alignment Healthcare, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Molina Healthcare, with an average 1-year price target of $363.56, suggesting a potential 14.36% downside.</li>
<li>Analysts currently favor an Outperform trajectory for HealthEquity, with an average 1-year price target of $111.11, suggesting a potential 73.83% downside.</li>
<li>Analysts currently favor an Buy trajectory for Alignment Healthcare, with an average 1-year price target of $18.19, suggesting a potential 95.72% downside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>In the peer analysis summary, key metrics for Molina Healthcare, HealthEquity and Alignment Healthcare are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Centene</td>
<td>Neutral</td>
<td>3.41%</td>
<td>$3.72B</td>
<td>1.05%</td>
</tr>
<tr>
<td>Molina Healthcare</td>
<td>Neutral</td>
<td>16.04%</td>
<td>$1.11B</td>
<td>5.42%</td>
</tr>
<tr>
<td>HealthEquity</td>
<td>Outperform</td>
<td>18.84%</td>
<td>$189.04M</td>
<td>1.24%</td>
</tr>
<tr>
<td>Alignment Healthcare</td>
<td>Buy</td>
<td>50.68%</td>
<td>$86.34M</td>
<td>-29.00%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Elevance Health ranks at the top for Revenue Growth among its peers. It is in the middle for Gross Profit. Elevance Health is at the bottom for Return on Equity.</p>
<h3>Unveiling the Story Behind Elevance Health</h3>
<p>Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.</p>
<h3>Key Indicators: Elevance Health's Financial Health</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Revenue Growth:</strong> Elevance Health displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>6.55%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> Elevance Health's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>0.92%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Elevance Health's ROE excels beyond industry benchmarks, reaching <strong>0.98%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Elevance Health's ROA excels beyond industry benchmarks, reaching <strong>0.36%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Elevance Health's debt-to-equity ratio is below the industry average. With a ratio of <b>0.76</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/ELV/earnings"><strong>To track all earnings releases for Elevance Health visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

A Look Ahead: Elevance Health's Earnings Forecast

<p>Throughout the last three months, 4 analysts have evaluated UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), offering a diverse set of opinions from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $642.5, a high estimate of $660.00, and a low estimate of $600.00. Witnessing a positive shift, the current average has risen by 1.02% from the previous average price target of $636.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244058_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The standing of UnitedHealth Group among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;    Analyst Firm    &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;Michael Wiederhorn  &#x7C;Oppenheimer         &#x7C;Lowers         &#x7C;Outperform     &#x7C;             $600.00&#x7C;$640.00             &#x7C;<br />
&#x7C;David Macdonald     &#x7C;Truist Securities   &#x7C;Raises         &#x7C;Buy            &#x7C;             $660.00&#x7C;$610.00             &#x7C;<br />
&#x7C;Ann Hynes           &#x7C;Mizuho              &#x7C;Raises         &#x7C;Outperform     &#x7C;             $650.00&#x7C;$600.00             &#x7C;<br />
&#x7C;Stephen Baxter      &#x7C;Wells Fargo         &#x7C;Lowers         &#x7C;Overweight     &#x7C;             $660.00&#x7C;$694.00             &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to UnitedHealth Group. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of UnitedHealth Group compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of UnitedHealth Group's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into UnitedHealth Group's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/UNH/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on UnitedHealth Group analyst ratings.</strong></a></p>
<h2>Delving into UnitedHealth Group's Background</h2>
<p>UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.</p>
<h3>Unraveling the Financial Story of UnitedHealth Group</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Positive Revenue Trend:</strong> Examining UnitedHealth Group's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>8.7%</strong> as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>5.74%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> UnitedHealth Group's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>6.5%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>2.07%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.81</strong>, UnitedHealth Group adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


What 4 Analyst Ratings Have To Say About UnitedHealth Group

<p>Deep-pocketed investors have adopted a bullish approach towards Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in WMT usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Walmart. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 3 are puts, totaling $105,236, and 5 are calls, amounting to $230,712.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $45.0 and $97.0 for Walmart, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Walmart's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Walmart's whale trades within a strike price range from $45.0 to $97.0 in the last 30 days. </p>
<h3>Walmart Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244056_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>WMT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$2.82</td>
<td>$2.75</td>
<td>$2.82</td>
<td>$95.00</td>
<td>$67.9K</td>
<td>6.3K</td>
<td align="right">571</td>
</tr>
<tr>
<td>WMT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$51.0</td>
<td>$51.0</td>
<td>$51.0</td>
<td>$45.00</td>
<td>$51.0K</td>
<td>277</td>
<td align="right">10</td>
</tr>
<tr>
<td>WMT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$4.6</td>
<td>$4.55</td>
<td>$4.6</td>
<td>$92.50</td>
<td>$48.7K</td>
<td>6.3K</td>
<td align="right">233</td>
</tr>
<tr>
<td>WMT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$2.2</td>
<td>$1.96</td>
<td>$2.0</td>
<td>$97.00</td>
<td>$42.0K</td>
<td>0</td>
<td align="right">211</td>
</tr>
<tr>
<td>WMT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$12.5</td>
<td>$11.4</td>
<td>$12.5</td>
<td>$90.00</td>
<td>$37.5K</td>
<td>12.4K</td>
<td align="right">30</td>
</tr>
</tbody>
</table>
</p>
<h3>About Walmart</h3>
<p>Walmart serves as a leading retailer in the United States, with its strategy predicated on superior operating efficiency and offering the lowest priced goods to consumers to drive robust store traffic and product turnover. Walmart augmented its low-price business strategy by offering a convenient one-stop shopping destination with the opening of its first supercenter in 1988.Today, Walmart operates over 4,600 stores in the United States (5,200 including Sam's Club) and over 10,000 locations globally. Walmart generated over $460 billion in domestic namesake sales in fiscal 2025, with Sam's Club contributing another $90 billion to the company's top line. Internationally, Walmart generated $120 billion in sales. The retailer serves around 270 million customers globally each week.</p>
<h3>Walmart's Current Market Status</h3>
<ul>
<li>With a trading volume of 1,377,166, the price of WMT is down by -0.39%, reaching $92.86.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 24 days from now.</li>
</ul>
<h3>What The Experts Say On Walmart</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $101.2.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Oppenheimer persists with their Outperform rating on Walmart, maintaining a target price of $100.<br />
&#x2A; An analyst from Mizuho has revised its rating downward to Outperform, adjusting the price target to $105.<br />
&#x2A; Maintaining their stance, an analyst from Stifel continues to hold a Hold rating for Walmart, targeting a price of $91.<br />
&#x2A; An analyst from Telsey Advisory Group persists with their Outperform rating on Walmart, maintaining a target price of $115.<br />
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Walmart, targeting a price of $95. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Walmart with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Behind the Scenes of Walmart's Latest Options Trends

<p>Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-22. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Intuitive Surgical will report an <strong>earnings per share</strong> (EPS) of $1.73.</p>
<p>The market awaits Intuitive Surgical's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings Track Record</h3>
<p>The company's EPS beat by $0.42 in the last quarter, leading to a 4.04% drop in the share price on the following day.</p>
<p>Here's a look at Intuitive Surgical's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.79</td>
<td>1.63</td>
<td>1.54</td>
<td>1.41</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.21</td>
<td>1.84</td>
<td>1.78</td>
<td>1.50</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-4.0%</td>
<td>10.0%</td>
<td>9.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745244051_0.png" alt="eps graph" /></p>
<h3>Tracking Intuitive Surgical's Stock Performance</h3>
<p>Shares of Intuitive Surgical were trading at $482.74 as of April 18. Over the last 52-week period, shares are up 25.2%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/ISRG/earnings"><strong>To track all earnings releases for Intuitive Surgical visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Comments

REX FANG & Innovation Equity Premium Income ETF

Actualités

Dernières nouvelles pour REX FANG & Innovation Equity Premium Income ETF (NASDAQ:FEPI)

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL